Fluidigm said today that Research Instruments/RI Technologies will distribute its products in Singapore and Thailand.
Under the agreement, Research Instruments will sell Fluidigm's complete portfolio of BioMark HD, EP1, and Access Array systems; the complete lineup of Dynamic Array, Digital Array, and Access Array integrated fluidic chips for real-time PCR, digital PCR, single-cell gene expression, sample prep for next-gen sequencing, and genotyping; and Fluidigm's new DELTAgene and SNPtype assays.
Founded in 1989, Research Instruments is based in Singapore, while subsidiary RI Technologies is based in Bangkok, Thailand.
The company distributes a range of products for life sciences research, including instruments and consumables for genomics, proteomics, cell biology research, whole animal in vivo imaging, and clinical studies, according to its website.